John Stuart Patton's Net Worth
$15.8 Million
Who is John Stuart Patton?
John Stuart Patton has an estimated net worth of $15.8 Million. This is based on reported shares across multiple companies, which include HALOZYME THERAPEUTICS INC, and NEKTAR THERAPEUTICS.
SEC CIK
John Stuart Patton's CIK is 0001247653
Past Insider Trading and Trends
2007 was John Stuart Patton's most active year for acquiring shares with 9 total transactions. John Stuart Patton's most active month to acquire stocks was the month of April. 2007 was John Stuart Patton's most active year for disposing of shares, totalling 387 transactions. John Stuart Patton's most active month to dispose stocks was the month of May. 2007 saw John Stuart Patton paying a total of $798,760.01 for 183,001 shares, this is the most they've acquired in one year. In 2014 John Stuart Patton cashed out on 150,000 shares for a total of $900,735.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HALOZYME THERAPEUTICS INC (HALO) Snapshot price: $59.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$6.01 | -$593,235.00 | 179.88K |
Aug 19
| |||
Form 4
| +16.05% | 24.88K |
—
|
—
| 179.88K |
May 13
| |||
Form 4
| +19.23% | 25K |
$4.76 | -$646,038.75 | 155K |
Sep 13 - Sep 16
| |||
Form 4
| +18.18% | 20K |
—
|
—
| 130K |
May 16
| |||
Form 4
| +22.22% | 20K |
—
|
—
| 110K |
May 3
| |||
Form 4
| +28.57% | 20K |
—
| $20.00 | 90K |
May 5
| |||
Form 4
| +40.00% | 20K |
—
| $20.00 | 70K |
May 6
| |||
Form 4
| +66.67% | 20K |
—
| $20.00 | 50K |
May 7
| |||
Form 4
| +100.00% | 15K |
$4.94 | $74,100.00 | 30K |
May 8
| |||
Form 4
| -50.00% | -15.00K |
$9.04 | -$135,628.00 | 15K |
Scheduled
|
Oct 16
| ||
Form 4
| -33.33% | -15.00K |
$8.69 | -$130,306.10 | 30K |
Scheduled
|
Oct 9
| ||
Form 4
| -25.00% | -15.00K |
$8.90 | -$133,470.72 | 45K |
Scheduled
|
Oct 2
| ||
Form 4
| -20.00% | -15.00K |
$8.94 | -$134,098.67 | 60K |
Scheduled
|
Sep 25
| ||
Form 4
| -18.89% | -17.47K |
$8.93 | -$156,004.69 | 75K |
Scheduled
|
Sep 18
| ||
Form 4
| -4.90% | -20.00K |
$9.83 | -$195,670.56 | 387.98K |
Scheduled
|
Jul 10
| ||
Form 4
| -6.80% | -8.20K |
$8.98 | -$73,643.00 | 112.47K |
Scheduled
|
Jun 26
| ||
Form 4
| -8.91% | -11.80K |
$8.66 | -$102,176.80 | 120.67K |
Scheduled
|
Jun 26
| ||
Form 4
| -13.12% | -20.00K |
$10.25 | -$205,067.73 | 132.47K |
Scheduled
|
Jun 19
| ||
Form 4
| -11.60% | -20.00K |
$10.05 | -$200,956.81 | 152.47K |
Scheduled
|
Jun 12
| ||
Form 4
| -10.39% | -20.00K |
$10.27 | -$205,317.25 | 172.47K |
Scheduled
|
May 29
| ||
Form 4
| -7.23% | -15.00K |
$10.50 | -$157,542.00 | 192.47K |
May 23
| |||
Form 4
| -8.79% | -20.00K |
$10.56 | -$211,129.00 | 207.47K |
Scheduled
|
May 22
| ||
Form 4/A
| -6.19% | -15.00K |
$10.37 | -$155,550.00 | 227.47K |
May 15
| |||
Form 4
| -5.61% | -15.00K |
$10.37 | -$155,550.00 | 252.17K |
May 15
| |||
Form 4
| -10.53% | -25.00K |
$9.13 | -$228,341.00 | 212.47K |
Scheduled
|
Apr 18
| ||
Form 4
| -9.52% | -25.00K |
$8.62 | -$215,389.65 | 237.47K |
Scheduled
|
Apr 11
| ||
Form 4
| -8.70% | -25.00K |
$8.36 | -$208,915.98 | 262.47K |
Scheduled
|
Apr 4
| ||
Form 4/A
| -8.00% | -25.00K |
$8.40 | -$209,979.41 | 287.47K |
Scheduled
|
Mar 28
| ||
Form 4
| -80.01% | -25.00K |
$8.40 | -$209,979.41 | 6.25K |
Scheduled
|
Mar 28
| ||
Form 4
| -7.41% | -25.00K |
$8.59 | -$214,870.00 | 312.47K |
Scheduled
|
Mar 21
| ||
Form 4
| -6.90% | -25.00K |
$8.01 | -$200,197.00 | 337.47K |
Scheduled
|
Mar 14 - Mar 15
| ||
Form 4
| +18.06% | 15K |
$2.80 | $42,000.00 | 98.05K |
May 4
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEKTAR THERAPEUTICS (NKTR) Snapshot price: $1.12
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.03% | -3.26K |
$4.37 |
—
| 313.88K |
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
| +0.97% | 3K |
$0.01 | $30.00 | 311.86K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
| +4.78% | 15K |
$0.01 | $150.01 | 328.54K |
Mar 9
| |||
Form 4
| +1,400.00% | 14K |
$13.29 | $186,060.00 | 15K |
Jan 26
| |||
Form 4
|
∞
| 1K |
$14.52 | $14,520.00 | 1K |
Jan 5
| |||
Form 4
| -72.67% | -1.63K |
$20.21 | -$33,002.93 | 614 |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +1.17% | 6.47K |
$9.91 | -$76,286.73 | 558.13K |
Mar 3 - Mar 7
| |||
Form 4
| -3.50% | -20.00K |
$22.00 | -$440,000.00 | 551.66K |
Scheduled
|
Jan 27
| ||
Form 4
| +11.29% | 58K |
$19.34 | $1,121,727.75 | 571.66K |
Jan 18 - Jan 19
| |||
Form 4
| -3.75% | -20.00K |
$20.04 | -$400,716.00 | 513.66K |
Scheduled
|
Jan 13
| ||
Form 4
| -0.73% | -3.90K |
—
|
—
| 533.66K |
Dec 14
| |||
Form 4
| -51.91% | -1.75K |
$14.47 | -$25,323.02 | 1.62K |
May 10
| |||
Form 4
| +0.25% | 2.68K |
$14.37 | -$21,368.19 | 1.07M |
Mar 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
| +6.28% | 31.6K |
$18.61 | $588,076.00 | 534.88K |
Jan 14
| |||
Form 4
| -0.79% | -4.03K |
—
|
—
| 503.28K |
Dec 16
| |||
Form 4
| -60.60% | -3.40K |
$19.42 | -$66,033.10 | 2.21K |
Dec 15
| |||
Form 4/A
|
∞
| 25K |
—
|
—
| 25K |
Mar 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| -0.30% | -20.00K |
$22.17 | -$443,522.00 | 6.6M |
Mar 4
| |||
Form 4
|
∞
| 25K |
$0.01 | $250.00 | 25K |
Mar 1
| |||
Form 4
| -3.65% | -20.00K |
$20.00 | -$400,000.00 | 527.31K |
Feb 10
| |||
Form 4
| -3.53% | -20.00K |
$18.19 | -$363,732.50 | 547.31K |
Scheduled
|
Jan 13
| ||
| No matching records found | |||||||||